Our current work reveals a novel molecular mechanism underlying SIRT1 ISGylation for the regulation of tumor progression and the response to DNA-damaging chemotherapeutics in lung cancer, as depicted in the summary schematic (Fig. 7i). The gene discussed is SIRT1; the disease is lung cancer.